DZIF - Deutsches Zentrum für Infektionsforschung

HIV antibody opens new approaches for vaccine development and combination therapies | German Center for Infection Research An international research team has identified a novel

🔬 A key step toward improved #HIV treatments and vaccine development: DZIF researchers have identified a novel HIV antibody, 007, which targets a particularly vulnerable site on the virus and overcomes the limitations of classical antibodies.

#HIVResearch @uniklinikkoeln.bsky.social

The AMR Conference is almost here!
✔️ Expert speakers
✔️ Startup Pitch finalists
✔️ Poster finalists
The stage is set for two days of bold ideas, innovation, and collaboration in antimicrobial resistance.

Have you secured your spot yet?

📍 Basel | 3–4 February 2026
Come find INCATE at Booth 9

Ethris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines | German Center for Infection Research Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategi

💉New partnership for next-gen mRNA vaccines: Ethris and DZIF combine proprietary, clinically-validated mRNA technology with translational vaccine research to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.

Today we celebrate International Day of Women and Girls in Science.

Women have shaped breakthroughs from microbiology to antibiotics, saving millions of lives worldwide.

At INCATE, equity isn’t optional — it’s foundational.

When women and girls succeed in science, society succeeds.

INCATE appoints first Chief Executive Officer to shape its future vision | German Center for Infection Research INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced a defining milestone in its instit

🎉 #INCATE appoints Dr. Holger Zimmermann as its first CEO: an important step in shaping the incubator’s future vision and supporting the development of anti-infectives at an early stage in the fight against antimicrobial resistance.

#AMR @incate.bsky.social

Technology transfer for Corallopyronin A successfully completed with Phyton Biotech | German Center for Infection Research Phyton Biotech has successfully transferred the manufacturing process for the microbial production of

💊 Phyton Biotech has successfully completed the technology transfer for manufacturing Corallopyronin A, a novel anti-infective agent that addresses neglected tropical diseases. This achievement paves the way for first-in-human clinical trials.

@helmholtzhzi.bsky.social @unibonn.bsky.social #NTDs

Harnwegsinfektionen: Weg zu weniger Breitband-Antibiotika Forschungsteam entwickelt schnelle, präzise und kostengünstige Methode zur Analyse der krankheitsverursachenden Bakterien und deren Antibiotika-Empfindlichkeit

Gezielte #Antibiose statt Breitband auf Verdacht: Ein neues Verfahren von @jlugiessen.bsky.social, @dzif.bsky.social, der Inland-Universität Norwegen, @uio.no und @au.dk gewinnt diagnostische Informationen aus Patientenproben in kürzester Zeit – und zeigt so, welche #Antibiotika wirksam sind.

Mourning the loss of Professor Oliver T. Keppler | German Center for Infection Research Professor Oliver T.

With deep sadness, we bid farewell to Professor Oliver T. Keppler, Chair of Virology at the Max von Pettenkofer Institute at Ludwig Maximilian University in Munich. He passed away on January 27, 2026 following a serious illness.

Powerful medicines against malaria resistance: New drug combinations prove safe, well tolerated, and effective | German Center for Infection Research Most

🦟 Researchers at the Bernhard Nocht Institute for Tropical Medicine evaluated new combinations of malaria drugs to overcome rising resistance. The results show that the new drugs are safe, well-tolerated, and as effective as standard therapy.

#Malaria #ClinicalTrials t1p.de/ajdb2

NAKO participates in the National Decade of Post-Infectious Diseases – German National Cohort (NAKO) The German National Cohort (NAKO) contributes its scientific expertise to the National Decade of Post-Infectious Diseases initiated by the Federal Ministry of Research, Technology and Space (BMFTR). W...

Infections leave traces – we want to understand them.
NAKO contributes its scientific expertise to the National Decade Against Post-Infectious Diseases initiated by the BMFTR. Dorothee Bär launched the National Decade on 30 January 2026.
📸 ©️BMFTR/Hans-Joachim Rickel
👉 nako.de/en/press-rel...

🎙️ Der neue #Infektiopod ist da! In der aktuellen Podcastfolge geht es um die spannendsten Paper und Veröffentlichungen aus dem Jahr 2025 mit Neuigkeiten zu Tuberkulose, Impfungen und dem Bakterium Staphylococcus aureus. @infektiopod.bsky.social

🔗 Jetzt reinhören: infektiopod.de/infektiopod-...

@leibniz-dsmz.bsky.social
Dangerous fungal infections - Leibniz Institute DSMZ provides foundation for their investigation
German Leibniz Institute DSMZ makes WHO-listed fungi available to researchers worldwide: www.dsmz.de/press/press-...

Auf der Suche nach Ursachen von #LongCOVID hat ein Team am @ciim-hannover.bsky.social Immunzellen von Patient:innen analysiert. Sie fanden molekulare Veränderungen in #Monozyten, die mit der Schwere von Fatigue, Atemwegssymptomen & Entzündungswerten korrelieren.
www.helmholtz-hzi.de/media-center...

World Neglected Tropical Diseases Day on January 30 | German Center for Infection Research The World

🌍Today is #WorldNTDDay: a reminder that millions of people are affected by diseases that are largely invisible on the global health agenda. Together with our African Partner Institutions, DZIF scientists are working to improve and develop diagnostics and therapies for neglected tropical diseases.

Call for the position as Helmholtz Junior Research Group Leaders at the Helmholtz Institute for RNA-based Infection Research or Helmholtz Institute for Pharmaceutical Research Saarland

Join the HZI as a Junior Research Group Leader at @helmholtz-hiri.bsky.social or @helmholtzhips.bsky.social!
We’re seeking exceptional postdocs for the @helmholtz.de Investigator Groups program. Shape cutting-edge research in infection biology & apply by Feb 15!
jobs.helmholtz-hzi.de/job/Saarbr%C...

Eine Hand in einem blauen Gummihandschuh bedient ein Gerät zur Nanopore-DNA-Sequenzierung, ein kleiner schwarzer Kasten, der oben offen ist.

Metagenom-basierte Schnelldiagnostik für #Harnwegsinfektionen könnte #Antibiotikaverbrauch senken: Forschungsteam von #JLUGiessen und @dzif.bsky.social entwickelt präzise und kostengünstige Methode zur Analyse von Bakterien und deren #Antibiotika-Empfindlichkeit www.uni-giessen.de/de/ueber-uns...

Preparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response | German Center for Infection Research A new study has shown for the first time that an experimental

💉Preparedness for future pandemics: A new long-term clinical study shows for the first time that a MERS vaccine candidate induces a stable, functional immune response in humans that persists for at least two years after a booster vaccination.

Join CARB-X Executive Director Kevin Outterson J.D., LL.M., ESQ, and CARB-X Senior Alliance Manager Su Chiang, PhD, at the inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)! #IDSky 🧪

🔗 Register here: bit.ly/49KL5Tg

Schutzmasken als Helfer für die Tuberkulose-Diagnostik Neues Diagnoseverfahren: Erbsubstanz von Tuberkulosebakterien in Atemschutzmasken bei Patienten mit einer Lungentuberkulose nachgewiesen

😷 Für die Diagnose der pulmonalen #Tuberkulose ist meist eine Sputumprobe nötig – doch nicht alle Patienten können genug #Sputum produzieren. Ein neuer Ansatz von @dzif.bsky.social / @fzborstel.bsky.social setzt auf Proben aus Atemschutzmasken.

Schleichende Gefahr: Resistenzen jenseits von Antibiotika Die drohende postantimikrobielle Ära betrifft auch Pilze, Viren und Parasiten. Forscher weltweit suchen nach neuen Wegen, um Resistenzmechanismen ausz...

#Resistenzen gehen weiter als gedacht: Nicht nur #Bakterien, sondern auch #Pilze & #Viren lernen, Therapien zu umgehen. Von invasiven Mykosen bis #HIV zeigt sich, dass die drohende postantimikrobielle Ära real ist. Mehr bei @pharmazeitung.bsky.social. www.pharmazeutische-zeitung.de/resistenzen-...

Oben eine Foto-Collage mit Menschen verschiedener Altersgruppen (u. a. Kinder, Paare, Familien), die sich umarmen oder lächeln, vor farbigen Hintergründen. Unten eine große blaue Fläche mit Text: „Impfempfehlungen der STIKO 2026 veröffentlicht“ „Wesentliche Änderungen und Ergänzungen zu den Empfehlungen 2025“

Die Impfempfehlungen der STIKO 2026 sind da!

Wesentliche Änderungen und Ergänzung zum Vorjahr betreffen:

🔵 RSV
🔵 Chikungunya
🔵 Influenza
🔵 Mpox
🔵 Hib
🔵 Herpes zoster
🔵 Meningokokken
🔵 Pneumokokken

Die gesamten Empfehlungen im #EpidBull:
➡️ rki.de/stiko-empfehlungen

🔬🦠𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗗𝗭𝗜𝗙/𝗣𝗘𝗚 𝗝𝗼𝗶𝗻𝘁 𝗠𝗲𝗲𝘁𝗶𝗻𝗴!
We are excited to invite you to the joint Annual Meeting of DZIF & PEG: Explore how infection research is evolving in the age of antibiotic resistance, gender medicine, and precision medicine

📅 February 23–24, 2026
📍 Bonn
🔗 Register now: t1p.de/dzif-peg-2026

📢🔜 New #DZG Seminar Series: Computational Topics in Biomedicine

🎙️Topic: Mapping the Human Body One Cell at a Time with Prof. Sarah Teichmann
🗓️ Thursday, January 22, 2026 | 5:00 PM
📍 Online (Zoom) / login via t1p.de/DZG-seminar

The seminar is open to all interested participants. #ResearchforHealth

Non-invasive diagnosis of tuberculosis using respiratory masks | German Center for Infection Research Diagnosis of pulmonary

😷Tuberculosis diagnosis without sputum! A new prospective study shows that sampling exhaled air with a face mask can detect tuberculosis bacteria, even in cases that sputum tests missed. This non-invasive method could be a promising addition to existing diagnostic techniques. @fzborstel.bsky.social

International consortium against antimicrobial resistance | German Center for Infection Research Prof.

🎉Congratulations to Prof. Rolf Müller on his appointment to the Scientific Advisory Board of the European Partnership on One Health Antimicrobial Resistance! This initiative aims to find new ways to treat and prevent resistant infections and fill existing knowledge gaps on #AMR @eupohamr.bsky.social

Basilea joins INCATE to support antifungal innovation - INCATE January 13, 2026 — INCATE (INCubator for Antibacterial Therapies in [...]

Starting 2026 with great news!
We are thrilled to welcome Basilea Pharmaceutica as a new industry partner. This collaboration not only brings strong antibacterial expertise but also expands our scope to antifungals.

Read here ➡️ www.incate.net/basilea-join...

Genanalyse eröffnet neue Wege zur Diagnose schwer erkennbarer Tuberkulose Wie tickt das Immunsystem bei Tuberkulose, wenn die Infektion andere Organe als die Lunge befällt?Forschende haben die immunologischen Eigenschaften der extrapulmonalen Tuberkulose (EPTB) im Blut von ...

Wie tickt das Immunsystem bei #Tuberkulose, wenn die Infektion andere Organe als die Lunge befällt? Forschende haben nun die immunologischen Eigenschaften der extrapulmonalen Tuberkulose im Blut von betroffenen Patientinnen und Patienten entschlüsselt.

🎉 Herzlichen Glückwunsch an Prof. Dr. Dirk Heinz und sein Team am @helmholtzhzi.bsky.social und @helmholtz-hiri.bsky.social zur aktuellen Veröffentlichung in @nature.com! 👏

Tuberkulose-Therapie: Antibiotikaresistenz durch AMS-Standards vermeiden Neue klinische Standards stärken „Antimicrobial Stewardship“ in der Tuberkuloseversorgung

Resistenzen gegen #Antibiotika nehmen weltweit zu – auch bei Wirkstoffen gegen #Tuberkulose. Experten aus 32 Ländern legen nun erstmals spezifische „Antimicrobial Stewardship“-Standards für die TB-Versorgung vor, berichtet @dzif.bsky.social. #Antibiotikaresistenz #AMS

📢 CARB-X Novel Chemistry for AMR Challenge!
CARB-X is seeking applications for novel chemistry plans against known #AMR targets. The aim is to unlock innovative starting points for therapeutics to address drug-resistant bacterial infections. #IDSky #ChemSky 🧪
🔗 bit.ly/4blmsyN